Global Self Monitoring Blood Glucose (SMBG) Device Market Growth 2025-2031

The global Self Monitoring Blood Glucose (SMBG) Device market size is predicted to grow from US$ 16730 million in 2025 to US$ 28920 million in 2031; it is expected to grow at a CAGR of 9.5% from 2025 to 2031.

Self-monitoring blood glucose (SMBG) device refers to portable instruments that can identify the possibilities of diabetes. These devices usually measure glucose levels by obtaining a small drop of blood from patients by pricking their fingers. International guidelines recommend this method for managing a patient’s diabetes successfully. The self-monitoring blood glucose (SMBG) device are used to measure the concentration of glucose in the blood.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry.

1. Key Features:
• Increasing demand for advanced healthcare services globally
• Advancements in medical technology
• Growing geriatric population
• Rising healthcare expenditure
• Increasing awareness about early disease diagnosis and treatment

Segmentation by Type:

• Self-Monitoring Blood Glucose Meters
• Continuous Glucose Monitors
• Testing Strips
• Lancets

Segmentation by Application:

• Hospital Pharmacy
• Retail Pharmacy
• Diabetes Clinic

Market by Region:

• Americas
• APAC
• Europe
• Middle East & Africa

Company's Coverage:

• Abbott Laboratories
• Bionime Corporation
• B.Braun Melsungen AG
• F.Hoffmann-La Roche Ltd.
• LifeScan Inc.
• PHC Holdings Corporation
• Home Diagnostics Inc.
• Terumo Pharmaceutical Solutions
• ARKRAY Inc.
• Ypsomed Holding AG
• Dexcom Inc.
• Medtronic PLC.
• Novo Nordisk
• Glysens Incorporated
• Senseonics Holdings
• Ascensia

Key Questions Addressed in this Report:

• What is the 10-year outlook for the global Self Monitoring Blood Glucose (SMBG) Device market?
• What factors are driving Self Monitoring Blood Glucose (SMBG) Device market growth, globally and by region?
• Which technologies are poised for the fastest growth by market and region?
• How do Self Monitoring Blood Glucose (SMBG) Device market opportunities vary by end market size?
• How does Self Monitoring Blood Glucose (SMBG) Device break out by Type, by Application?